Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy) Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...

United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025 Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...

Diet Pills Global Market Report 2024: The Rise of Plant-Based and Technological Innovations Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Diet Pills Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest market research sheds light on the remarkable...

Zepbound™ New Injectable Weight Loss Medication Coming to St. Louis St Louis, MO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Food and Drug Administration has granted approval for Zepbound™, an innovative weight loss medication developed by Eli Lilly. In clinical trials,...

Key Trends and Opportunities in the Global Weight Loss Products and Services Market to 2026 Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Weight Loss Products and Services Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for weight...